Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.50 |
| ▸ | MAX | P61244 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | IDE | P14735 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
| ▸ | CCR6 | P51684 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | COMT | P21964 | 1/20 | 0.39 |
| ▸ | ATIC | P31939 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL11321734 | 0.89 | TTR (0.46) | MYCMAXTTRALDH1A1CYP1A2 | |
| SCHEMBL6666484 | 0.87 | MYC (0.57) | MYCMAXTTRALDH1A1CYP1A2 | |
| SCHEMBL9670672 | 0.84 | TTR (0.47) | MYCMAXTTRALDH1A1CYP1A2 | |
| SCHEMBL28338713 | 0.83 | ALDH1A1 (0.55) | MYCMAXTTRALDH1A1CYP1A2 | |
| SCHEMBL28338912 | 0.82 | ALDH1A1 (0.53) | MYCMAXTTRALDH1A1CYP1A2 | |
| SCHEMBL28457455 | 0.82 | ALDH1A1 (0.53) | MYCMAXTTRALDH1A1CYP1A2 | |
| SCHEMBL31391239 | 0.77 | MYC (0.63) | MYCMAXALDH1A1KMT2ARAB9A | |
| SCHEMBL30354640 | 0.76 | TTR (0.56) | TTRALDH1A1CYP1A2MAPTATIC | |
| SCHEMBL660151 | 0.76 | TTR (0.56) | TTRALDH1A1CYP1A2MAPTATIC | |
| SCHEMBL31742344 | 0.76 | TTR (0.56) | TTRALDH1A1CYP1A2MAPTATIC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100098630-A1 | Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides | AMBRX, INC. (US) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100098630-A1 | Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides | PTMS, NPEPPS, DNPEP | MYC 346/4885MAX 88/4885TTR 1346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.